Physician profile
Bryan Ong
NPI 1649901224
$2,185.63
in general payments reported to CMS, 2019-2025
9 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 95% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $530 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $527.29 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Getinge USA Sales, LLC | $287.64 | 2024-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Penumbra, INC. | $280.08 | 2025 | Penumbra System, Indigo System |
| Cvrx, INC. | $263.34 | 2025 | Barostim Neo System |
| Medical Device Business Services, INC. | $243.33 | 2024-2025 | Vistaseal, Evarrest |
| Silk Road Medical, INC. | $179.65 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Core Surgical Group | $168.27 | 2025 | |
| Becton, Dickinson and Company | $132.30 | 2025 | Hemosphere |
| Medtronic, INC. | $103.73 | 2024 | Avalus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.